Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Clinical significance of drug induced QTprolongation and related syndromes: an update The importantance of cardiac repolarization reserve in safety pharmacology András Varró Department of Pharmacology and Pharmacotherapy University of Szeged, Hungary Albert Szent-Györgyi Medical Center 2007 Torsades de pointes „QT interval prolongation, with the potential for fatal arrhythmias, has been the single most common cause of withdrawal or relabeling of marketed drugs in the last decade” (Roden et al. J.Clin.Invest. 115:2025-2032; 2005) RARE: with terfenadine 1/50000 Developmental cost Withdrawal cost: ~ 800 million USD ~ 500 - ? million USD Due to Torsades de pointes: Withdrawn drugs Terfenadine Astemizole Grepafloxacin Cisapride None approval or suspended development several Complicated approval Moxifloxacin Ziprasidone Approved with QT cautions in labeling numerous Re-labeling Thioridazine Droperidol „If you remember, I did mention possible side-effects.” Drugs That Prolong the Q-T Interval and/or Induce Torsades de Pointes www.Torsades.org Raymond L. Woosley, MD, Ph.D. Arizona CERT (Center for Education and Research on Therapeutics) Information from the FDA-approved drug labeling and the medical literature. Closed and last revised: 03/01/2006 Current clinical view of drug induced torsade pointes arrhythmia Primary drug effect (IKr IHERG blockade) Secondary risk factors (effect amplifiers) – High doses or rapid administration – Metabolic inhibition – Impaired elimination – Bradycardia – Hypokalemia ; hypomagnesemia – Heart disease (CHF, LVF, diabetes) – Female gender 70 % E. Kevin Heist et al. Heart Rhythm 2005;2:S1–S8 – Concomittant ion-channel modifier – Undetected ion channel polymorphisms or mutation( LQT) Moxifloxacin (fluroquinolone) as positive control 6 – 10 ms QT prolongation QT lengthening Important antiarrhythmic mechanism Sign of dangereous side effect of various drugs Regional differences Gaborit et al. J Physiol 582.2 (2007) pp 675–693 regular heart beat regular heart beat extrasystole extrasystole 1 ERP ERP 2 3 7 4 ERP ERP 6 ERP 5 ERP Experimental demonstration of the repolarization reserve The effect of IKs block on the APD in dog right ventricular muscle and Purkinje fiber PURKINJE FIBER VENTRICULAR MUSCLE CONTROL 100 nM L-735,821 0 mV 50 mV 0 mV 200 ms CONTROL 10 µM CHROMANOL 293B 0 mV 50 mV 0 mV 200 ms Varro et al. J Physiol. 2000;523:67-81. Experimental demonstration of the repolarization reserve The effect of IKs block in pharmacologically lengthened APD in dog right ventricular muscle CONTROL E-4031 + VERATRINE + 100 nM L-735,821 + 100 nM L-735,821 0 mV 50 mV 1 µM E-4031 + 1 µg/ml VERATRINE 420 400 380 100 ms 340 320 300 280 260 240 220 0 20 40 60 80 100 120 140 APD CHANGE (%) APD (ms) 360 TIME (min) Varro et al. J Physiol. 2000;523:67-81. 20 18 16 14 12 10 8 6 4 2 0 n=8 * * n=7 Conclusion in 2000 Varro et al. J Physiol. 2000;523:67-81. Role of IKs in the repolarization reserve in the human ventricle Jost et al., Circulation. 2005; 112:1393-1400. Multiple K+ channel block and repolarization reserve Dofetilide + Chromanol 293B 0 mV 50 mV Chromanol 293B IKs CL = 5000 ms IKr 0 mV 200 ms EAD 50 mV 200 ms IKr+ IKs 50 mV 0 mV Dofetilide + BaCl2 0 mV 0 mV IK1 CL = 5000 ms 200 ms IKr 50 mV 50 mV BaCl2 200 ms IKr+ IK1 200 ms Bilicki et al. Br J Pharmacol 2002; 137: 361-368 Repolarization Reserve 200 ms CHANNEL PROTEIN CURRENT Nav1.5+Navb1 INa Cav1.2+Cava2d1 ICa Kv4.3+Kv1.4 KChIP2 Ito (H)ERG+miRP1 IKr KvLQT1+minK IKs Kir 2.1 (Kir2.x) Ik1 NCX INCX The role of repolarization reserve in patients Sotalol test Kääb et al. 2003; Eur Heart Journal The role of repolarization reserve in patients Number of Subjects Ibutilide test Ibutilide test Change in QTc (msec) Kilborn et al. Circulation 2000. 102: II-673 Decreased repolarization reserve due to ventricular electrophysiological remodelling Pharmacogenetics (LQT syndrome, ion-channel polymorphysm etc.) Gender Ischaemia Renal failure Diabetes Drugs Heart failure DIAMOND-CHF Trial and repolarization reserve Placebo-treated patients Cumulative mortality Dofetilide-treated patients QTc < 454ms 0.5 QTc > 454ms QTc > 454ms 0.4 0.3 0.2 QTc < 454ms 0.1 0.0 0 1 2 3 Years QTc Interval as Guide to Select Those Patients With Congestive Heart Failure … Brendorp et al. Circulation 2001; 103:1422-1427 Repolarization reserve and gender Rodriguez et al. JAMA 2001, Vol 285:1322-1326 Cisapride rescues misprocessed mutant (LQT3) sodium channel trafficing Liu et al. Circulation. 2005;112:3239-3246. How to predict torsades de pointes arrhythmia ? HERG assay ? Action potential duration in dog Pf ? QTc ? QT dispersion ? APD triangularization (SCREENIT system – Hondeghem) ? QT/APD short term variability ? Variability of Repolarization What does it mean? spatial temporal Purkinje fiber, M-cell, Subendocardial, Subepicardial,Basal, Apex beat-to-beat How to measure? QT or APD Varriability index Berger et al., Circulation, 1997 Short-term beat-to-beat varriability STV Dn1 Dn 30 2 Brennan et al. IEEE, 2001; 48:1342-47 240 QT interval (Dn+1; ms) QTv / QTm2 QTvi log 10 2 HRv / HRm Poincaré plot 220 200 180 160 140 120 120 140 160 180 200 QT interval (Dn; ms) 220 240 Different effects of sotalol and amiodarone – two drugs lengthening QT – on the short term repolarization variability Thomsen et al, Circulation. 2004; 110:2453-2459. Combined IKr plus IKs block in the ventricular myocyte: beat-to-beat variability of repolarization Volders et al. Circulation. 2003;107:2753-2760 Effects of IKr-blocker dofetilide and IKs-blocker HMR-1556 on QT-interval variability in conscious dogs TdP + Dog 1 QT-interval n (s) 0,5 0,4 0,3 0,2 Dog 2 Dog 3 Dog 4 Dog 5 0.5 0,5 0,5 0,5 0,5 0.4 0,4 0,4 0,4 0,4 0.3 0,3 0,3 0,3 0,3 0.2 0,2 0,2 0,2 0,2 0 0 0,1 0.2 0.3 0.4 QT-interval n-1 (s) 0 0.5 0 0,1 0.2 0.3 0.4 QT-interval n-1 (s) 0,1 0,1 0,2 0,3 0,4 0.2 0.3 0.4 QT-interval n-1 (s) 0 0 0 0 0.5 0 0,5 0,1 0,2 0,3 0.5 0 0.2 0.3 0.4 QT-interval n-1 (s) 0 0 0,4 0,1 0,1 0,5 0,2 0,3 0,4 0,1 0.5 0 0.2 0.3 0.4 QT-interval n-1 (s) 0.5 0 0 0,5 0,1 0,2 0,3 0,4 0 0,5 0,1 0,2 0,3 0,4 0,5 TdP – Dog 7 Dog 6 QT-interval n (s) 0,5 0,4 0,3 0,2 Dog 8 0.5 0,5 0.4 0,4 0.3 0,3 0,3 0.2 0,2 0,2 Control 0,5 Dofetilide (0.025 mg/kg) 0,4 Dofetilide (0.025 mg/kg) + HMR-1556 (1 mg/kg) 0 0 0,1 0.2 0.3 0.4 QT-interval n-1 (s) 0 0 0.5 0,1 0.2 0.3 0.4 QT-interval n-1 (s) 0,1 0,2 0,3 0,4 0 0.2 0 0 0 0.5 0,1 0 0,5 0,1 0,2 0,3 0,4 0,5 0 0,1 0,2 0.3 0.4 QT-interval n-1 (s) 0.5 Lengyel et al. Br J of Pharmacol 2007; advance online publication 0,3 0,4 0,5 Changes in cardiac repolarization in patients with heart failure Changes in cardiac repolarization in patients treated with antipsychotic drugs Controls (n = 11) Heart failure patients (n =711) 500 450 * 6 500 * * 400 5 250 4 3 200 150 300 ms ms 300 4 350 ms 350 ms 5 * 450 400 250 200 2 2 100 1 50 0 QTc 1 50 0 0 0 QT 3 150 100 QT-STV 60 Percentage change (%) Percentage change (%) Controls (n = 41) Psychiatric patients (n = 54) 50 40 30 20 10 QT QTc QT-STV QT QTc QT-STV 35 30 25 20 15 10 5 0 0 QT QTc QT-STV -5 Drug indrustry Development of life saving drugs (antiarrhythmics, cardiotonics, AIDS drugs etc.) Endpoint: mortality Development of quality of life improving drugs (pl. antihistamins, CNS and GI drugs etc.) Endpoint: not mortality „I guess we should have tried it on the rats first.” General conclusion 1. We should first reach a concensus what degree or any kind of mortality can be tolerated. 2. Before treatment we should assess the susceptability of the patients regarding possible QT lengthening (repolarization reserve) 3. In the future during drug development, to design and control safety pharmacology studies deeper cardiac electrophysiological background and further basic research is required. ”Are you coming hunting, or are you gonna sit around here all day inventing?” Specific conclusion considering the role of repolarization reserve 1. Cardiac muscle has strong safety margin of repolarization („REPOLARIZATION RESERVE”). Decrease of this repolarization reserve does not necessarily lead to marked change of repolarization but makes hearts susceptible to arrhythmias. 2. Multiple K+ channel block can result excessive repolarization lengthening by eliminating the repolarization reserve and therefore it can associate with increased proarrhythmic risk. “Are you sure about this, Dave? It seems odd that a pointy head and long beak is what makes them fly.”